IDT Biologika News

Read about the latest news and developments at IDT Biologika, including the company’s growth, innovations and community involvement.
You can also access our entire archive of press releases and follow our activity on social media.

30 new laboratories for the vaccines of the future more info

Official transfer of ownership more info

Rockville expands the IDT vaccine development and production offer more info

CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine

Monday, 20. August 2018

CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine more info

25th anniversary of the privatization of IDT Biologika

Friday, 29. June 2018

Prime Minister hails exemplary success story more info

IDT Biologika acquires Dr. Felgenträger, located in the BioPharmaPark Dessau

Tuesday, 24. April 2018

The pharmaceuticals company intends to use this takeover to continue expanding its herd-specific vaccine business more info

CMO Leadership Award 2018

Monday, 26. March 2018

IDT Biologika receives three Life Science Leader’s more info

A second managing director for IDT Biologika

Monday, 19. February 2018

Our new senior management team is now complete more info

Twitter
@IDT Biologika

Wednesday, 12. September 2018

RT @CEPIvaccines: Since first being identified in 2012, #MERS has claimed nearly 800 lives out of 2,229 confirmed cases. We are now workin… more info

Tuesday, 21. August 2018

RT @CEPIvaccines: Today, we announced a partnership with German company @IDTBiologika to develop a #MERS vaccine. Germany's Federal Ministe… more info

Tuesday, 21. August 2018

RT @BMBF_Bund: @idtbiologika -Geschäftsführer Andreas Kastenbauer unterzeichnete heute den Vertrag mit der CEPI. Die Forschenden aus Dessau… more info

External Corporate Communications

If you are a journalist and have any questions, please don't hesitate to contact us.

Kontaktformular

Christian Herschel

External Corporate Communications